175 related articles for article (PubMed ID: 18425841)
1. Detection of choline signal in human breast lesions with chemical-shift imaging.
Baek HM; Chen JH; Yu HJ; Mehta R; Nalcioglu O; Su MY
J Magn Reson Imaging; 2008 May; 27(5):1114-21. PubMed ID: 18425841
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
3. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
4. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.
Jacobs MA; Barker PB; Bottomley PA; Bhujwalla Z; Bluemke DA
J Magn Reson Imaging; 2004 Jan; 19(1):68-75. PubMed ID: 14696222
[TBL] [Abstract][Full Text] [Related]
6. (1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.
Mizukoshi W; Kozawa E; Inoue K; Saito N; Nishi N; Saeki T; Kimura F
Eur Radiol; 2013 Jan; 23(1):75-83. PubMed ID: 22777619
[TBL] [Abstract][Full Text] [Related]
7. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
8. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.
Sun K; Chai W; Fu C; Zhan Y; Shen K; Luo X; Yan F
Eur Radiol; 2016 Jun; 26(6):1565-74. PubMed ID: 26385807
[TBL] [Abstract][Full Text] [Related]
10. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Proton Magnetic Resonance Spectroscopy and 18F-Fluorocholine PET to Differentiate Benign From Malignant Breast Lesions.
Wu LA; Yen RF; Shih TT; Chen KL; Wang J
Clin Nucl Med; 2021 Nov; 46(11):896-903. PubMed ID: 34606485
[TBL] [Abstract][Full Text] [Related]
12. Human breast lesions: characterization with proton MR spectroscopy.
Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
[TBL] [Abstract][Full Text] [Related]
13. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
[TBL] [Abstract][Full Text] [Related]
14. 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.
Wang X; Wang XJ; Song HS; Chen LH
Med Oncol; 2015 May; 32(5):160. PubMed ID: 25895597
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
16. Comparison and Optimization of 3.0 T Breast Images Quality of Diffusion-Weighted Imaging with Multiple B-Values.
Han X; Li J; Wang X
Acad Radiol; 2017 Apr; 24(4):418-425. PubMed ID: 27955879
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types.
Baek HM
ScientificWorldJournal; 2012; 2012():508295. PubMed ID: 22654620
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
20. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
Tozaki M; Fukuma E
AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]